Clinical Trial Update: Letrozole in Patients With Hepatopulmonary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update on letrozole for hepatopulmonary syndrome; the study was terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatopulmonary Syndrome

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: Mayo Clinic | Conditions: Hepatopulmonary Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2024-05-14